Celgene Corp (CELG)

CELG (NASDAQ:Drugs) EQUITY
$121.16
pos +2.50
+2.11%
Today's Range: 118.81 - 121.19 | CELG Avg Daily Volume: 4,302,200
Last Update: 02/17/17 - 4:14 PM EST
Volume: 4,858,957
YTD Performance: 4.67%
Open: $119.13
Previous Close: $118.66
52 Week Range: $92.98 - $137.54
Oustanding Shares: 777,966,471
Market Cap: 92,313,501,449
6-Month Chart
TheStreet Ratings Grade for CELG
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 15 15 14 15
Moderate Buy 0 0 0 0
Hold 2 2 2 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.24 1.24 1.25 1.33
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 47.65
Price Earnings Comparisons:
CELG Sector Avg. S&P 500
47.65 47.70 30.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-0.75% 15.05% 47.82%
GROWTH 12 Mo 3 Yr CAGR
Revenue 21.30 0.70 0.20
Net Income 24.80 0.40 0.11
EPS 28.40 0.50 0.14
Earnings for CELG:
EBITDA 3.71B
Revenue 11.23B
Average Earnings Estimates
Qtr (03/17) Qtr (06/17) FY (12/17) FY (12/18)
Average Estimate $1.47 $1.60 $6.60 $8.16
Number of Analysts 8 4 4 3
High Estimate $1.55 $1.67 $6.83 $8.50
Low Estimate $1.41 $1.54 $6.51 $7.80
Prior Year $1.18 $1.28 $5.18 $6.60
Growth Rate (Year over Year) 24.58% 24.61% 27.46% 23.59%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
RMPIA
By

Doug Kass

 | Feb 15, 2017 | 3:49 PM EST
I started the day with a discussion of the new administration's policies and why I believe there are headwinds to their passage over the next few months or quarters. 
RMPIA
By

Jim Cramer

 | Feb 15, 2017 | 3:34 PM EST
Some tried-and-true indicators show what's really going on with the market.
RMPIA
By

Doug Kass

 | Feb 13, 2017 | 3:08 PM EST
 
RMPIA
By

Jim Cramer

 | Feb 8, 2017 | 11:24 AM EST
Jim Cramer compares Allergan's growth to other pharma stocks.
RMPIA
By

Bret Jensen

 | Feb 1, 2017 | 11:30 AM EST
Carrot-stick 'arrangement' with biotech is a fair tradeoff but will produce winners and losers.
RMPIA
By

Doug Kass

 | Jan 31, 2017 | 4:27 PM EST
The U.S. dollar weakened on Navarro's comments. The price of crude oil was flattish, closing slightly under $53 a barrel. Gold up $19. Booyah. See my comments on gold during the day. I have a large position now and will grow larger on ANY weakness. Ag commodities rebounded from yesterday's schmeissing: wheat up $0.07, corn $0.02, soybeans $0.02 and oats up $0.01. Lumber up $7, an outsized gain for now explicable reason. Bonds rallied and I possess a contrary view that rates are headed lower. Yields dropped by 2-4 basis points the yield curve made no change. Municipals were bid for. Closed-end muni-bond funds higher. Junk bonds continued lower, albeit only slightly. Blackstone / GSO Strategic Credit Fund (BGB) +$0.07 as the spread between high yield and treasuries continues the persistent contraction of the last few months. Banks were a downside standout. And so where insurance and brokerages. See my comments above. Retail was the surprise, rebounding from the UAA-induced early morning weakness. Perhaps my trading idea was right, after all. Autos were mixed and my pairs trade was slightly negative after the recent strong gains. Ag equipment broadly lower led by fav short, Caterpillar (CAT) . Consumer staples prospered as our currency weakened. Campbell Soup (CPB) small profit taking, Coca-Cola (KO) still no fizz. Biotech was up 3%, led by Allergan (up $6.50!), Celgene (CELG) and Gilead Sciences (GILD) . Speculative biotech, after days of weakness, was on fire. Media was lower, Disney (DIS) reversed yesterday's gains. Big pharma liked what it heard in Washington, D.C (T)FANG was bad, bad -- with only Tesla (TSLA) higher. In individual stocks, Radian (RDN) looks like it is about to make a run for the roses -- and its only January! Apple down small ahead of earnings. Oaktree Capital (OAK) quietly moving higher, again! A good thing -- it will soon be springtime and hopefully the Mighty Oak will grow expansively. Here are some value added columns on our site today: 1. Jim "El Capitan" Cramer, unlike myself, is a buyer of banks " over the long run."  2. Carley Garner on large speculative shorts in Treasuries, something I have written about in the past. 3. Ed Ponsi "Scheme" likes gold, a kindred spirit. he discusses the gold/currency relationship in his good analysis.  4. Steve Blitz "Kreig" on jobs.  5. Rev Shark on dip buying, or lack thereof... and the consequences.    Positions -- Long: HIG large, RDN, AGN, GLD large, OAK, JCP small, F, CPB large Short: AAPL, SPY, QQQ, IWM small, BAC small, C small, JPM small, GS, MET, LNC, DIS small, CAT short, KO small, GM
RMPIA
By

Doug Kass

 | Jan 30, 2017 | 4:09 PM EST
The U.S. dollar is stronger today. Oil dropped by a half buck to $52.63. Gold added $6. Ag commodities: wheat down $0.06, corn down $0.04, soybeans down $0.27 (!!) and oats down $0.08. (Be careful fertilizer freaks! Me, no like.) Lumber down $3. Bonds were quiet with small gains in yield and a two basis point increase in the 2s/10s spread. Municipals were up small in price -- as were closed-end muni-bond funds. High yield was junky, but Blackstone/GSO Strategic Credit Fund (BGB) was unchanged. Banks got hit -- I explained further why I have a trading short in sector in my Diary today (and above). When the stocks went up every day, commentary was omnipresent in the business media. Now, crickets. Insurance schmeissed, though my long, Hartford Financial (HIG)  , was barely lower. Brokerages got hit, Goldman Sachs (GS) was a feature to the downside. Retail showed signs of life -- a good thing. Several up 1% to 2% in a down tape (Nordstrom (JWN) , Walmart (WMT) , Kohl's (KSS) and J.C. Penney (JCP) ). Sears looks Chapter 11. (See above.) Biotech down 1.5% led by long fav Allergan (AGN) and Celgene (CELG) . Speculative biotech was particularly weak (FibroGen (FGEN) , Aerie Pharmaceuticals (AERI) , Intrexon (XON) ). Autos were lower but divergence between Ford (F) and General Motors (GM) is terrific for my pairs trade which is "kicking into gear." Ag equipment schmeissed, including fav large-cap short for 2017, Caterpillar (CAT) . Fertilizers wounded (see my comments about ag commodities, above). Consumer staples were mixed to lower. Campbell Soup (CPB) was higher most of the day, but faded in the afternoon. Coca-Cola (KO) still has no fizz despite some technical support mentioned last week on ReaLMoneyPro. Media was mixed. Disney (DIS) up, Comcast (CMCSA) down. Homebuilders appeared to have had a false breakout about a week ago and are lower again after recent weakness in last few days. (T)FANG hit on immigration ban (Silicon Valley is among the most diverse areas of the country) -- all five down, led by Amazon (AMZN) , which declined $5. In individual stocks, normal profit taking in DuPont (DD) (I have been whittling down and now I am small-sized -- what a winner its been over last 14 months!) Radian (RDN) resisting the lower market. Apple down small in front of this week's earnings report. Here are some value-added contributions on our site today: 1. Jim "El Capi
RMPIA
By

Bret Jensen

 | Jan 30, 2017 | 10:00 AM EST
M&A, drug approvals and Trump are all on my watch list.
RMPIA

bullishCelgene estimates, target raised at Credit Suisse

Jan 27, 2017 | 6:51 AM EST
Shares of CELG now seen reaching $148, according to Credit Suisse. Estimates also increased, as management continues to execute well. Outperform rating.
RMPIA
By

Doug Kass

 | Jan 26, 2017 | 4:08 PM EST
The U.S. Dollar strengthened. The price of crude oil rose by over one dollar to $53.78/barrel. Gold fell by -$8.60 to $1189. Ag commodities: wheat +2.50, corn -2.50, soybean -7 and oats -5.5. Lumber increased by $1.50. Bonds rallied in price after an early morning spill. Yields dropped by two basis points. The yield curve was flat. Municipal bonds were flat, as were closed end muni bond funds. Junk was unchanged, Blackstone/GSO Strategic Credit Fund (BGB)  down $0.03. Banks prospered, though Citigroup (C) was lower. Insurance was mixed after a Metlife (MET) downgrade. Brokerages solid, led by GS (short and on Best Ideas List). Big pharma continues out of favor after large downside at Bristol-Myers (BMY) . Johnson & Johnson (JNJ) continues weak, after M&A announcement. Retail continues to underperform and the possible 20% tariff from Mexico (that Sean Spicer just mentioned) won't help. Nor will the possibility of a Sears (SHLD) bankruptcy (plenty of discounted merchandise could cause some indigestion over the next few months. Old media was mixed, awaiting Microsoft (MSFT) EPS this afternoon. Biotech continued its fade led by Allergan (AGN) , Celgene (CELG) and Gilead Sciences (GILD) . Speculative biotech also got hit. Consumer staples faltered despite the currency weakness. Campbell Soup (CPB) and Procter &

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.